Stay updated with breaking news from Program Steering Committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
) proudly announces the winners of the SunBridge Emerging Leader Award for 2022. Each year, this award recognizes one innovative high-growth company from Japan
Abelacimab: First Factor XI Inhibitor to Enroll Patients in a Phase 3 Clinical Trial - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Anthos Therapeutics, a clinical-stage biopharma company developing innovative therapies for cardiovascular and metabolic diseases, today...
/PRNewswire/ -- Anthos Therapeutics, a clinical-stage biopharma company developing innovative therapies for cardiovascular and metabolic diseases, today...
Christian Steil and Savannah Rogers will join the industry association's prestigious Leadership Advancement & Development (LEAD) Program, which assembles,...